Our study on cardiac toxicity in lung cancer treatment is now featured in a JCO CCI editorial. Discoveries that could change patient care are on the horizon. Stay tuned! #CardiacToxicity#LungCancer#Innovation Shining a Light: Unveiling Cardiac Risks Using Positron Emission Tomography Imaging in Lung Cancer Radiotherapy
Our paper “Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy” has been published in JCO CCI. This research work delves into an innovative approach to predict clinical cardiac assessment using functional imaging. Abstract: Traditional methods for evaluating cardiotoxicity primarily focus on radiation doses to the heart. However, functional imaging offers the potential to enhance early prediction of cardiotoxicity in lung cancer patients undergoing radiotherapy. In this context, Fluorine-18 (18F) fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) imaging plays a crucial role. This study aims to develop a radiomics model that predicts clinical cardiac assessment using 18F-FDG PET/CT scans before thoracic radiation therapy. ...
AAPM Annual Meeting (Houston, TX • July 23 ‒ 27, 2023) Novel Functional Delta-Radiomics for Predicting Overall Survival in Lung Cancer Radiotherapy Using Cardiac FDG-PET Uptake Wookjin Choi, Yevgeniy Vinogradskiy Interactive ePoster Discussions: Sunday, July 23, 2023: 3:00 PM - 3:30 PM, GRBCC, Exhibit Hall | Forum 6 SU-300-IePD-F6-4 Novel Functional Delta-Radiomics for Predicting Overall Survival in Lung Cancer Radiotherapy Using Cardiac FDG-PET Uptake Deep Learning Segmentation for Accurate GTV and OAR Segmentation in MR-Guided Adaptive Radiotherapy for Pancreatic Cancer Patients Wookjin Choi, Hamidreza Nourzadeh, Yingxuan Chen, Christopher G. Ainsley, Vimal K. Desai, Alexander A. Kubli, Yevgeniy Vinogradskiy, Maria Werner-Wasik, Adam Mueller, and Karen E. Mooney PO-GePV-D-50 Deep Learning Segmentation for Accurate GTV and OAR Segmentation in MR-Guided Adaptive Radiotherapy for Pancreatic Cancer Patients ...